TIAMULIN MARKET ANALYSIS

Regional Analysis

Tiamulin Market: Regional Analysis

North America is expected to hold a dominant position in the global Tiamulin market over the forecast period, owing to the presence of key players in the region along with several strategic mergers and acquisitions amongst the key players. For instance, in 2015, US-based Eli Lilly and Company acquired Novartis Animal Health Inc. and its product –Denagard (tiamulin hydrogen fumarate) and strengthen the position of Eli Lilly and Company’s animal health business arm Elanco US, Inc.

Asia Pacific tiamulin market is expected to witness significant growth over forecast period, owing to increase in the number of pig farms in the region. For instance, according to report by Federal Statistical Office in 2014, China was the largest producer of pork with around 48% of the total pork produced worldwide. Such increasing production of pork is expected to propel the demand for antibiotics such as Tiamulin for the treatment of pigs.

Furthermore, Europe tiamulin market is expected to witness significant growth over the forecast period, owing to high rates of pork production, which is expected to increase demand for antibiotic drugs, such as Tiamulin. For instance, according to a report by National Pork Board, Europe is the second largest producer of pork worldwide with around 23,866 thousand metric tons pork produced in 2016 and 23,675 thousand metric tons pork produced in 2017.